Usefulness of Tc-99m-GSA scintigraphy for liver surgery

Annals of Nuclear Medicine

Volumn 25, Issue 9, 2011, Pages 593-602

  Kaibori, Masaki ^a   Ha Kawa, Sang Kil ^a   Maehara, Minoru ^a   Ishizaki, Morihiko ^a   Matsui, Kosuke ^a   Sawada, Satoshi ^a   Kwon, A Hon ^a  

^a KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

GSA Rmax; Hepatectomy; Hepatitis C virus; Hepatocellular carcinoma; Living donor liver transplantation; Regeneration

Indexed keywords

GALACTOSYLNEOGLYCOALBUMIN TC 99M; HUMAN SERUM ALBUMIN TC 99M;

CANCER PATIENT; CHRONIC HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER SCINTISCANNING; LIVER SURGERY; LIVER TRANSPLANTATION; LIVING DONOR; LOGISTIC REGRESSION ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK; SCINTIGRAPHY; VIRUS INFECTION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; RADIONUCLIDE IMAGING; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 81855176030     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0520-0     Document Type: Review

References (55)

1. AG Morell RA Irvine I Sternlieb IH Scheunberg G Ashwell 1968 Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo J Biol Chem 243 155 159 5635941 1:CAS:528: DyaF1cXisl2jug%3D%3D
2. WE Pricer G Ashwell 1971 The binding of desialylated glycoproteins by plasma membranes of rat liver J Biol Chem 246 4825 4833 4327329 1:CAS:528:DyaE3MXksFylsb4%3D
3. JB Burgess JU Baenziger WR Brown 1992 Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis Hepatology 15 702 706 1372583 10.1002/hep.1840150425 1:STN:280:DyaK383gtFOruw%3D%3D
4. T Sawamura S Kawasato Y Shiozaki Y Sameshima H Nakada Y Tashiro 1981 Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats Gastroenterology 81 527 533 7250640 1:CAS:528:DyaL3MXltFaqtb0%3D (Pubitemid 11061553)
5. T Sawamura H Nakada H Hazama Y Shiozaki Y Sameshima Y Tashiro 1984 Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: asiaroglycoprotein receptor in cirrhosis and liver cell carcinoma Gastroenterology 87 1217 1221 6092193 1:STN:280:DyaL2M%2FivVamug%3D%3D (Pubitemid 15201417)
6. SK Ha-Kawa Y Tanaka S Hasebe Y Kuniyasu K Koizumi Y Ishii, et al. 1997 Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study Eur J Nucl Med 24 130 137 9021109 10.1007/BF02439544 1:STN:280:DyaK2s7nsVWhsQ%3D%3D (Pubitemid 27121091)
7. AH Kwon SK Ha-Kawa S Uetsuji T Inoue Y Matsui Y Kamiyama 1997 Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy Hepatology 25 426 429 9021958 10.1002/hep.510250228 1:STN:280: DyaK2s7nsVahtg%3D%3D (Pubitemid 27069066)
8. J Wu N Ishikawa T Takeda Y Tanaka XQ Pan M Sato, et al. 1995 The functional hepatic volume assessed by 99mTc-GSA hepatic scintigraphy Ann Nucl Med 9 229 235 8770291 10.1007/BF03168406 1:STN:280:DyaK28zms1Witg%3D%3D (Pubitemid 26014377)
9. T Ota M Seki R Morita 1997 Case report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy Clin Radiol 52 399 401 9171799 10.1016/S0009-9260(97)80140-7 1:STN:280:DyaK2szhsFOqtg%3D%3D (Pubitemid 27220038)
10. S Tomiguchi T Kira Y Oyama M Nabeshima R Nakashima A Tsuji, et al. 1995 Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis Clin Nucl Med 20 717 720 7586877 10.1097/00003072-199508000- 00013 1:STN:280:DyaK28%2FgvV2ksQ%3D%3D
11. M Kaibori SK Ha-Kawa Y Uchida M Ishizaki T Hijikawa T Saito, et al. 2006 Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy Dig Dis Sci 51 2013 2017 16977504 10.1007/s10620-006-9534-1 1:CAS:528:DC%2BD28Xht1eru7jP (Pubitemid 44832582)
12. M Kaibori SK Ha-Kawa Y Uchida M Ishizaki T Saito K Matsui, et al. 2007 Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation Dig Dis Sci 53 850 855 17676394 10.1007/s10620-007- 9902-5
13. M Kaibori SK Ha-Kawa M Ishizaki K Matsui T Saito AH Kwon, et al. 2008 HA/GSA-Rmax ratio as a predictor of postoperative liver failure World J Surg 32 2410 2418 18758848 10.1007/s00268-008-9725-3
14. X Bosch J Ribes J Borras 1999 Epidemiology of primary liver cancer Semin Liver Dis 19 271 285 10518307 10.1055/s-2007-1007117 1:STN:280: DyaK1Mvks1Gktw%3D%3D (Pubitemid 29488770)
15. SD Taylor-Robinson GR Foster S Arora S Hargreaves HC Thomas 1997 Increase in primary liver cancer in the UK 1979-94 Lancet 350 1142 1143 9343506 10.1016/S0140-6736(05)63789-0 1:STN:280:DyaK1c%2FgtlWjtA%3D%3D (Pubitemid 27454010)
16. HB EI-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 10.1056/NEJM199903113401001 (Pubitemid 29114292)
17. ST Fan EC Lai CM Lo IO Ng J Wong 1995 Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis Arch Surg 130 198 203 7848092 1:STN:280:DyaK2M7ltVyhsw%3D%3D
18. DE Nadig TP Wada RB Fairchild KS Virgo FE Johnson 1997 Major hepatic resection Arch Surg 132 115 119 9041911 1:STN:280:DyaK2s7psVCksQ%3D%3D
19. M Shimada K Takenaka Y Fujiwara T Gion K Shirabe K Yanaga, et al. 1998 Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma Br J Surg 85 195 198 9501814 10.1046/j.1365-2168.1998.00567.x 1:STN:280:DyaK1c7mt1Cgtw%3D%3D (Pubitemid 28099936)
20. CN Yeh MF Chen WC Lee LB Jeng 2002 Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis J Surg Oncol 81 195 202 12451624 10.1002/jso.10178 (Pubitemid 35397151)
21. E Benzoni A Cojutti D Lorenzin GL Adani U Baccarani A Favero, et al. 2007 Liver resective surgery: a multivariate analysis of postoperative outcome and complication Langenbecks Arch Surg 392 45 54 16983576 10.1007/s00423-006-0084-y (Pubitemid 46147484)
22. CA Redaelli JF Dufour M Wagner M Schilling J Husler L Krahenbuhl, et al. 2002 Preoperative galactose elimination capacity predicts complications and survival after hepatic resection Ann Surg 235 77 85 11753045 10.1097/00000658-200201000-00010 (Pubitemid 34062402)
23. J Bruix A Castells J Bosch F Feu J Fuster JC Garcia-Pagan, et al. 1996 Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure Gastroenterology 111 1018 1022 8831597 10.1016/S0016-5085(96)70070-7 1:STN:280:DyaK28vivVCqtg%3D%3D (Pubitemid 26327605)
24. H Lau K Man ST Fan WC Yu CM Lo J Wong 1997 Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy Br J Surg 84 1255 1259 9313707 10.1002/bjs.1800840917 1:STN:280:DyaK2svlvV2gsA%3D%3D (Pubitemid 27400276)
25. M Makuuchi T Kosuge T Takayama S Yamazaki T Kakazu S Miyagawa, et al. 1993 Surgery for small liver cancers Semin Surg Oncol 9 298 304 8210909 10.1002/ssu.2980090404 1:STN:280:DyaK2c%2FitlKltw%3D%3D (Pubitemid 23216368)
26. RH Pearl GHA Clowes S Bosari WV McDermott JO Menzoian W Love, et al. 1987 Amino acid clearance in cirrhosis. A predictor of postoperative morbidity and mortality Arch Surg 122 468 473 3551882 1:STN:280:DyaL2s7osVSisQ%3D%3D (Pubitemid 17051877)
27. RA Gill MW Goodman GR Golfus GR Onstad MP Bubrick 1983 Aminopyrine breath test predicts surgical risk for patients with liver disease Ann Surg 198 701 704 6639175 10.1097/00000658-198312000-00006 1:STN:280:DyaL2c%2FltFClug%3D%3D (Pubitemid 14202745)
28. T Kitai T Inomoto M Miwa T Shikayama 2005 Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer Breast Cancer 12 211 215 16110291 10.2325/jbcs.12.211
29. I Miyashiro N Miyoshi M Hiratsuka K Kishi T Yamada M Ohue, et al. 2008 Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: Comparison with infrared imaging Ann Surg Oncol 15 1640 1643 18379850 10.1245/s10434-008-9872-7 (Pubitemid 351668160)
30. K Gotoh T Yamada O Ishikawa H Takahashi H Eguchi M Yano, et al. 2009 A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation J Surg Oncol 100 75 79 19301311 10.1002/jso.21272
31. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Intraoperative indocyanine green fluorescent imaging for prevention of bile leakage after hepatic resection. Surgery. 2011;150(1):91-8.
32. T Suou S Yamada K Hosho N Yoshikawa H Kawasaki 1996 Relationship between serum and hepatic 7s fragments of type IV collagen in chronic liver disease Hepatology 23 1154 1158 8621148 10.1002/hep.510230533 1:STN:280: DyaK283gs1GntQ%3D%3D (Pubitemid 26137061)
33. K Horii S Kubo K Hirohashi H Kinoshita 1999 Changes in erythrocyte deformability after liver resection for hepatocellular carcinoma associated with chronic liver disease World J Surg 25 85 90 10.1007/s002689900570 (Pubitemid 28565565)
34. Y Shimahara N Yamamoto N Uyama H Okuyama H Momoi T Kamikawa, et al. 2002 Significance of serum type IV collagen level of hepatectomized patients with chronic liver damage World J Surg 26 451 456 11910479 10.1007/s00268-001-0248-4 (Pubitemid 36920392)
35. S Kubo T Tsukamoto K Hirohashi H Tanaka T Shuto S Takemura, et al. 2003 Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus World J Surg 27 437 442 12658489 10.1007/s00268-002-6475-5 (Pubitemid 36920118)
36. S Yachida H Wakabayashi Y Kokudo F Goda S Okada T Maeba, et al. 2000 Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy World J Surg 24 359 364 10658073 10.1007/s002689910057 1:STN:280:DC%2BD3c7is1Cgtw%3D%3D (Pubitemid 30117767)
37. T Mizuguchi T Katsuramaki T Nobuoka M Kawamoto H Oshima H Kawasaki, et al. 2004 Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy World J Surg 28 971 976 15573250 10.1007/s00268-004-7389-1 (Pubitemid 40109879)
38. T Kanematsu K Takenaka T Matsumata T Furuta K Sugimachi K Inokuchi 1984 Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer Ann Surg 199 51 56 6318677 10.1097/00000658-198401000-00009 1:STN:280:DyaL2c7gtlentA%3D%3D (Pubitemid 14218874)
39. M Kaibori Y Matsui T Hijikawa Y Uchida AH Kwon Y Kamiyama 2006 Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C Surgery 139 385 394 16546504 10.1016/j.surg.2005.08.035
40. Hayashi M, Fujii K, Kiuchi T, Uryuhara K, Kasahara M, Takatsuki M, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transpl Proc. 1999;31:403. (Pubitemid 29127503)
41. T Ito T Kiuchi H Egawa S Kaihara F Oike Y Ogura, et al. 2003 Surgery-related morbidity in living donors of right lobe liver graft: lessons from the first 200 cases Transplantation 76 158 163 12865803 10.1097/01.TP.0000072372.42396.47 (Pubitemid 36877130)
42. JY Cho K-S Suh CH Kwon NJ Yi KU Lee 2006 Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired Surgery 139 508 515 16627060 10.1016/j.surg.2005.09.007
43. M Iwasaki Y Takada M Hayashi S Minamiguchi H Haga Y Maetani, et al. 2004 Noninvasive evaluation of graft steatosis in living donor liver transplantation Transplantation 78 1501 1505 15599315 10.1097/01.TP.0000140499.23683.0D (Pubitemid 39552937)
44. 99mTc-galactosyl serum albumin Kakuigaku 30 1333 1339 1:STN:280:DyaK2c7gsVWhtQ%3D%3D (in Japanese with English abstract) (Pubitemid 24031624)
45. EA Pomfret JJ Pomposelli FD Gordon N Erbay L Lyn Price WD Lewis, et al. 2003 Liver regeneration and surgical outcome in donors of right-lobe liver grafts Transplantation 76 5 10 12865779 10.1097/01.TP.0000079064.08263.8E (Pubitemid 36877107)
46. A Humar K Kosari TD Sielaff B Glessing M Gomes C Dietz, et al. 2004 Liver regeneration after adult living donor and deceased donor split-liver transplants Liver Transpl 10 374 378 15004764 10.1002/lt.20096 (Pubitemid 38380311)
47. AH Kwon Y Matsui SK Ha-Kawa Y Kamiyama 2001 Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography Am J Gastroenterol 96 541 546 11232703 10.1111/j.1572-0241.2001.03556.x 1:STN:280:DC%2BD3M7ot12msA%3D%3D
48. AC Baltz JF Trotter 2003 Living donor liver transplantation and hepatitis C Clin Liver Dis 7 651 665 14509532 10.1016/S1089-3261(03)00058-8 (Pubitemid 37093424)
49. EJ Gane BC Portmann NV Naoumov HM Smith JA Underhill PT Donaldson, et al. 1996 Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 815 820 8596547 10.1056/NEJM199603283341302 1:STN:280: DyaK287ns1aktg%3D%3D (Pubitemid 26099603)
50. LM Forman JD Lewis JA Berlin HI Feldman MR Lucey 2002 The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 889 896 11910340 10.1053/gast.2002.32418 (Pubitemid 34267271)
51. M Berenguer L Ferrell J Watson M Prieto M Kim M Rayón, et al. 2000 HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 673 684 10782918 10.1016/S0168-8278(00)80231-7 1:STN:280:DC%2BD3c3ktlSisA%3D%3D (Pubitemid 30180389)
52. D Samuel T Bizollon C Feray B Roche SN Ahmed C Lemonnier, et al. 2003 Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 642 650 12612903 10.1053/gast.2003.50095 1:CAS:528:DC%2BD3sXisVKntr8%3D (Pubitemid 36268483)
53. Kiuchi T, Uemoto S, Egawa H, Kaihara S, Oike F, Yokoi A, et al. Living donor liver transplantation in Kyoto, 2001. Clin Transpl. 2001;195-201.
54. K Ishak A Baptista L Bianchi F Callea J De Groote F Gudat, et al. 1995 Histological grading and staging of chronic hepatitis J Hepatol 22 696 699 7560864 10.1016/0168-8278(95)80226-6 1:STN:280:DyaK28%2FjsFWntw%3D%3D
55. P Bedossa T Poynard 1996 An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 289 293 8690394 10.1002/hep.510240201 1:STN:280:DyaK28zhvFClug%3D%3D (Pubitemid 26260021)